Ignite Creation Date:
2025-12-24 @ 7:47 PM
Ignite Modification Date:
2025-12-29 @ 1:23 AM
Study NCT ID:
NCT06668103
Status:
RECRUITING
Last Update Posted:
2024-12-12
First Post:
2024-10-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Clinical Study of Combination Therapy With ABSK043 and Firmonertinib
Sponsor:
Abbisko Therapeutics Co, Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-11-25
Start Date Type:
ACTUAL
Primary Completion Date:
2027-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2024-10-30
First Submit QC Date:
None
Study First Post Date:
2024-10-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-09
Last Update Post Date:
2024-12-12
Last Update Post Date Type:
ACTUAL